Category: St. Jude MedicalSyndicate content

St. Jude Medical touts 1st U.S. implant of 'leadless' Nanostim pacemaker

February 6, 2014 by Chris Walker

St. Jude Medical implants the 1st U.S. patient with its Nanostim leadless pacemaker, which is implanted directly in the heart.

St. Jude Medical touts 1st U.S. implant of 'leadless' Nanostim pacemaker

St. Jude Medical (NYSE:STJ) today touted the 1st U.S. implant of its Nanostim pacemaker, a leadless device implanted directly into the heart to help regulate abnormal heart rhythms.

Medtech trends: The most talked about device makers in January 2014

February 4, 2014 by Arezu Sarvestani

MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.

chart

Click to enlarge.

MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.

St. Jude Medical shuffles the deck

January 28, 2014 by Brad Perriello

St. Jude Medical says it will merge its 2 main divisions and streamline its worldwide manufacturing operations, promoting Michael Rousseau to COO and announcing the retirement of cardiovascular and ablation president Frank Callaghan.

St. Jude Medical shuffles the deck

St. Jude touts 1st U.K. implant of 'leadless' Nanostim pacemaker

January 27, 2014 by Arezu Sarvestani

St. Jude Medical implants the 1st U.K. patient with its Nanostim pacemaker, the 1st heart rhythm moderating device of its kind implanted directly in the heart.

Corrected January 28, 2014, 11:45 a.m.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Riata lawsuit claims stand against St. Jude Medical

January 27, 2014 by Brad Perriello

Five product liability lawsuits filed against St. Jude Medical over its recalled Riata defibrillator leads withstand a bid to dismiss claims that St. Jude failed to warn about problems with the leads.

Riata lawsuit claims stand against St. Jude Medical

St. Jude Medical beats The Street with Q4, 2013 numbers

January 22, 2014 by Brad Perriello

St. Jude Medical's 4th-quarter and 2013 results exceed expectations on Wall Street, sending share prices up today in pre-market trading.

St. Jude Medical beats The Street with Q4, 2013 numbers

St. Jude Medical (NYSE:STJ) topped expectations on Wall Street with its 4th-quarter and 2013 results, prompting early-bird investors to send share prices up today in pre-market trading.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien bails on renal denervation

January 21, 2014 by Brad Perriello

Covidien said it's pulling the plug on its OneShot renal denervation device, citing the slow development of the hypertension market.

Covidien bails on renal denervation

Covidien (NYSE:COV) said it plans to wind down its OneShot renal denervation program, largely due to "slower than expected development of the renal denervation market," meaning the end for a U.S. clinical trial of the high blood pressure device.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp